Medicine
Mozobil 24 mg/1.2 mL injection
Mozobil 24 mg/1.2 mL injection is a prescription medicine containing Plerixafor for subcutaneous use, marketed by Sanofi-Aventis, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 25°C (77°F), excursions permitted to 15°C–30°C (59°F–86°F).
Key facts
- Active ingredient (INN)
- Plerixafor
- Brand
- Mozobil
- Strength
- 24 mg/1.2 mL
- Dosage form
- Injection
- Route
- Subcutaneous
- Packs
- 1 vial of 1.2 mL
- Marketing authorisation holder
- Sanofi-Aventis
- Manufacturer
- Sanofi-Aventis
- Origin register
- US FDA, United States
- Storage
- Store at 25°C (77°F), excursions permitted to 15°C–30°C (59°F–86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L03AX16 Plerixafor
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 September 2013
- Identifiers
- RxCUI 828700, 828703DailyMed set ID 0ed08d2b-5051-46b2-aa37-1d6275bf9003NDC 0024-5862Application NDA022311
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-use in 1 carton / 1.2 mL in 1 vial, single-use | 0024-5862-01 | Sanofi-Aventis | 1 September 2013 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Plerixafor 24 mg/1.2 mL injection.
Clinical summary
Plerixafor is a hematopoietic stem cell mobilizer. It is available as injection for subcutaneous use. MedsAcross supplies Plerixafor for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PlerixaforFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Plerixafor prescribing information (Fresenius Kabi) · U.S. National Library of Medicine, DailyMed
- Mozobil: European public assessment report (EPAR) · European Medicines Agency
- Plerixafor Accord: European public assessment report (EPAR) · European Medicines Agency
Need Mozobil 24 mg/1.2 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.